A critical assessment of the medication-related osteonecrosis of the jaw classification in stage I patients: a retrospective analysis

키워드

참고문헌 (41)

1. Robert E Marx, "Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic", Journal of Oral and Maxillofacial Surgery, 61(9), pp.1115~1117 (2003), Elsevier BV[DOI]
2. Massimo Viviano, "A case of bisphosphonate-related osteonecrosis of the jaw with a particularly unfavourable course: a case report", 대한구강악안면외과학회지, 43(4), pp.272~275 (2017), 대한구강악안면외과학회
3. Aliya A. Khan, "Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ", Journal of Clinical Densitometry, 20(1), pp.8~24 (2017), Elsevier BV[DOI]
4. 김경민, "Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons", 대한골대사학회지, 22(4), pp.151~165 (2015), 대한골대사학회
5. 091: antiresorptiva-assoziierte kiefernekrosen (AR-ONJ), "S3-leitlinie 007", pp.2017, Schiegnitz E
6. Noam Yarom, "Medication-Related Osteonecrosis of the Jaw: MASCC", ISOO, Journal of Clinical Oncology, pp.2019, 37(25)[DOI]
7. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, "American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws", Journal of Oral and Maxillofacial Surgery, 65(3), pp.369~376 (2007), Elsevier BV[DOI]
8. Salvatore L. Ruggiero, "American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update", Journal of Oral and Maxillofacial Surgery, 67(5), pp.2~12 (2009), Elsevier BV[DOI]
9. Salvatore L. Ruggiero, "American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update", Journal of Oral and Maxillofacial Surgery, 72(10), pp.1938~1956 (2014), Elsevier BV[DOI]
10. Stefano Fedele, "Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed", British Journal of Oral and Maxillofacial Surgery, 53(1), pp.13~17 (2015), Elsevier BV[DOI]
11. Morten Schiodt, "Workshop of European task force on medication‐related osteonecrosis of the jaw—Current challenges", Oral Diseases, 25(7), pp.1815~1821 (2019), Wiley[DOI]
12. Ascani G, "Current controversies in classification, management, and prevention of bisphosphonate-related osteonecrosis of the jaw", Int J Dent, 2014, pp.565743~ (2014)[DOI]
13. A Bedogni, "Learning from experience. Proposal of a refined definition and staging system for bisphosphonate‐related osteonecrosis of the jaw (BRONJ)", Oral Diseases, 18(6), pp.621~623 (2012), Wiley[DOI]
14. Franco S, "New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol : long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the University of Bari", Int J Dent, 2014, pp.935657~ (2014)[DOI]
15. Ichiro Ogura, "Quantitative SPECT", CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis, 2019, pp.33(10), 776~782[DOI]
16. Taro Okui, "Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging", Annals of Nuclear Medicine, 34(9), pp.620~628 (2020), Springer Science and Business Media LLC[DOI]
17. S. Bisdas, "Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients", Clinical Radiology, 63(1), pp.71~77 (2008), Elsevier BV[DOI]
18. H. Devlin, "Detecting the earliest radiological signs of bisphosphonate-related osteonecrosis", British Dental Journal, 224(1), pp.26~31 (2018), Springer Science and Business Media LLC[DOI]
19. Sven Otto, "Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases", Cancer Treatment Reviews, 69, pp.177~187 (2018), Elsevier BV[DOI]
20. Alexandre T. Assaf, "Intraoperative efficiency of fluorescence imaging by Visually Enhanced Lesion Scope (VELscope®) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ)", Journal of Cranio-Maxillofacial Surgery, 42(5), pp.e157~e164 (2014), Elsevier BV[DOI]
21. O. Ristow, "Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study", International Journal of Oral and Maxillofacial Surgery, 46(2), pp.157~166 (2017), Elsevier BV[DOI]
22. Oliver Ristow, "Differences between auto-fluorescence and tetracycline-fluorescence in medication-related osteonecrosis of the jaw—a preclinical proof of concept study in the mini-pig", Clinical Oral Investigations, 24(12), pp.4625~4637 (2020), Springer Science and Business Media LLC[DOI]
23. Oliver Ristow, "Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw – A single center cohort study", Journal of Cranio-Maxillofacial Surgery, 46(5), pp.815~824 (2018), Elsevier BV[DOI]
24. Stefano Fedele, "Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series", The American Journal of Medicine, 123(11), pp.1060~1064 (2010), Elsevier BV[DOI]
25. Morten Schiodt, "Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 117(2), pp.204~213 (2014), Elsevier BV[DOI]
26. Ourania Nicolatou‐Galitis, "Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents", Oral Diseases, 26(5), pp.955~966 (2020), Wiley[DOI]
27. Oliver Ristow, "Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake—A randomized pilot trial", Oral Diseases, 27(3), pp.532~546 (2021), Wiley[DOI]
28. Noam Yarom, "Is Exposure of the Jawbone Mandatory for Establishing the Diagnosis of Bisphosphonate-Related Osteonecrosis of the Jaw?", Journal of Oral and Maxillofacial Surgery, 68(3), pp.705~ (2010), Elsevier BV[DOI]
29. Alexandre T. Assaf, "Intraindividual comparison of preoperative 99mTc-MDP SPECT", CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw, 2015, pp.43(8), 1461~1469[DOI]
30. Aliya A Khan, "Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus", Journal of Bone and Mineral Research, 30(1), pp.3~23 (2015), Wiley[DOI]
31. Saki Hayashida, "Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis", Journal of Bone and Mineral Research, 32(10), pp.2022~2029 (2017), Wiley[DOI]
32. Oliver Ristow, "Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study", Journal of Cranio-Maxillofacial Surgery, 47(3), pp.491~499 (2019), Elsevier BV[DOI]
33. Jens Philipp Bodem, "Value of nonsurgical therapeutic management of stage I bisphosphonate-related osteonecrosis of the jaw", Journal of Cranio-Maxillofacial Surgery, 43(7), pp.1139~1143 (2015), Elsevier BV[DOI]
34. Massimo Albanese, "Conservative non‐surgical management in medication related osteonecrosis of the jaw: A retrospective study", Clinical and Experimental Dental Research, 6(5), pp.512~518 (2020), Wiley[DOI]
35. Filippo Moretti, "A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws", Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 112(6), pp.777~782 (2011), Elsevier BV[DOI]
36. Salvatore L. Ruggiero, "Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw", Journal of Oral and Maxillofacial Surgery, 73(12), pp.S94~S100 (2015), Elsevier BV[DOI]
37. 강상훈, "The effect of bisphosphonate discontinuation on the incidence of postoperative medication-related osteonecrosis of the jaw after tooth extraction", 대한구강악안면외과학회지, 46(1), pp.78~83 (2020), 대한구강악안면외과학회[DOI]
38. 김윤호, "Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw", 대한구강악안면외과학회지, 40(5), pp.206~210 (2014), 대한구강악안면외과학회
39. Kamile Leonardi Dutra, "Prevalence of radiographic findings on jaws exposed to antiresorptive therapy: a meta-analysis", Dentomaxillofacial Radiology, 48(3), pp.20180112~ (2019), British Institute of Radiology[DOI]
40. Catalina Moreno-Rabié, "Early imaging signs of the use of antiresorptive medication and MRONJ: a systematic review", Clinical Oral Investigations, 24(9), pp.2973~2989 (2020), Springer Science and Business Media LLC[DOI]
41. Makoto Tsuchimochi, "Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (1), role of imaging in drug-related osteonecrosis of the jaw: An up-to-date review (secondary publication)", Japanese Dental Science Review, 55(1), pp.1~4 (2019), Elsevier BV[DOI]

관련 논문AI추천